Empire Life Investments’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-70,137
| Closed | -$5.89M | – | 113 |
|
|
2025
Q3 | $5.89M | Sell |
70,137
-92,410
| -57% | -$7.61M | 0.34% | 66 |
|
|
2025
Q2 | $12.9M | Sell |
162,547
-18,905
| -10% | -$1.5M | 0.82% | 46 |
|
|
2025
Q1 | $16.3M | Sell |
181,452
-151,378
| -45% | -$14.1M | 1.06% | 33 |
|
|
2024
Q4 | $33.1M | Buy |
332,830
+14,939
| +5% | +$1.54M | 2.08% | 11 |
|
|
2024
Q3 | $36.1M | Sell |
317,891
-48,542
| -13% | -$5.77M | 2.2% | 11 |
|
|
2024
Q2 | $45.4M | Sell |
366,433
-102,029
| -22% | -$13.1M | 2.86% | 8 |
|
|
2024
Q1 | $61.8M | Sell |
468,462
-10,475
| -2% | -$1.29M | 3.8% | 2 |
|
|
2023
Q4 | $52.2M | Sell |
478,937
-12,780
| -3% | -$1.33M | 3.37% | 4 |
|
|
2023
Q3 | $50.6M | Sell |
491,717
-3,514
| -0.7% | -$379K | 3.71% | 2 |
|
|
2023
Q2 | $57.1M | Buy |
495,231
+2,045
| +0.4% | +$232K | 3.9% | 2 |
|
|
2023
Q1 | $52.5M | Sell |
493,186
-57,458
| -10% | -$6.2M | 3.73% | 3 |
|
|
2022
Q4 | $61.1M | Sell |
550,644
-179,872
| -25% | -$18.4M | 4.19% | 3 |
|
|
2022
Q3 | $62.9M | Buy |
730,516
+11,868
| +2% | +$1.06M | 4.78% | 3 |
|
|
2022
Q2 | $65.5M | Sell |
718,648
-67,980
| -9% | -$6.03M | 4.72% | 3 |
|
|
2022
Q1 | $64.5M | Sell |
786,628
-10,495
| -1% | -$827K | 4.13% | 2 |
|
|
2021
Q4 | $61.1M | Buy |
797,123
+11,808
| +2% | +$940K | 3.72% | 3 |
|
|
2021
Q3 | $59M | Buy |
785,315
+127,488
| +19% | +$9.7M | 3.87% | 2 |
|
|
2021
Q2 | $51.2M | Buy |
657,827
+228,511
| +53% | +$17M | 3.29% | 6 |
|
|
2021
Q1 | $31.6M | Sell |
429,316
-13,495
| -3% | -$995K | 2.17% | 16 |
|
|
2020
Q4 | $34.6M | Sell |
442,811
-44,512
| -9% | -$3.4M | 2.44% | 13 |
|
|
2020
Q3 | $38.6M | Buy |
487,323
+35,532
| +8% | +$2.78M | 3.1% | 10 |
|
|
2020
Q2 | $33.3M | Buy |
451,791
+143,414
| +47% | +$10.8M | 2.93% | 11 |
|
|
2020
Q1 | $22.6M | Buy |
308,377
+4,916
| +2% | +$386K | 2.07% | 17 |
|
|
2019
Q4 | $26.3M | Buy |
303,461
+1,726
| +0.6% | +$142K | 2% | 22 |
|
|
2019
Q3 | $24.2M | Buy |
301,735
+18,075
| +6% | +$1.45M | 2.03% | 20 |
|
|
2019
Q2 | $22.7M | Buy |
283,660
+48,054
| +20% | +$3.68M | 1.83% | 19 |
|
|
2019
Q1 | $18.7M | Sell |
235,606
-191
| -0.1% | -$14.3K | 1.57% | 26 |
|
|
2018
Q4 | $17.2M | Sell |
235,797
-47,356
| -17% | -$3.34M | 1.55% | 27 |
|
|
2018
Q3 | $19.2M | Sell |
283,153
-19,194
| -6% | -$1.22M | 1.46% | 28 |
|
|
2018
Q2 | $17.5M | Buy |
302,347
+1,437
| +0.5% | +$81.1K | 1.26% | 31 |
|
|
2018
Q1 | $15.6M | Buy |
300,910
+5,606
| +2% | +$303K | 1.11% | 37 |
|
|
2017
Q4 | $15.9M | Buy |
295,304
+1,464
| +0.5% | +$81.2K | 1.22% | 32 |
|
|
2017
Q3 | $18M | Buy |
293,840
+98,849
| +51% | +$5.99M | 1.45% | 27 |
|
|
2017
Q2 | $11.9M | Buy |
194,991
+494
| +0.3% | +$30.1K | 1.04% | 42 |
|
|
2017
Q1 | $11.5M | Sell |
194,497
-33,167
| -15% | -$2.01M | 1.12% | 38 |
|
|
2016
Q4 | $12.6M | Buy |
+227,664
| New | +$13.3M | 1.02% | 40 |
|
Other funds holding MRK
Empire Life Investments's MRK Position: Q4 2025 in Review
Empire Life Investments sold out of Merck (MRK) in Q4 2025, closing a stake of 70,137 shares — an estimated $5.89M sold.
Empire Life Investments first reported a position in MRK in Q4 2016 and held it in 36 quarters. The position peaked at $65.5M in Q2 2022. 3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Empire Life Investments reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
- Empire Life Investments sold 70,137 Merck shares in Q4 2025, an estimated $5.89M.
- Empire Life Investments first reported a position in Merck in Q4 2016 and held it in 36 quarters.
- Empire Life Investments's Merck position peaked at $65.5M in Q2 2022.
- 3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Empire Life Investments's 13F filing for Q4 2025, filed 4 Feb 2026.